Asia Pacific Healthcare 3D Printing Market size crossed USD 302 million in 2021 and is projected to showcase around 21.3% growth rate between 2022 and 2028.

Healthcare 3D printing is a technique that is used to create three-dimensional anatomical structures such as blood vessels, organs, and bones, among others. Also, healthcare 3D printing provides personalized surgery, patient-specific anatomic replicas as well as enhanced surgical tools. They utilize different technologies such as fused deposition modelling, selective laser sintering and stereolithography among others to develop several models.

Get more details on this report - Request Free Sample PDF

The healthcare 3D printing market growth in Asia Pacific is due to technological advancements that has enabled enormous contributions in medical sector. The 3D printing developments in healthcare have led to safer, customizes, stronger & lighter products, cost effective and reduced time with better understanding of anatomical and pathological structures. Therefore, medical professionals use 3D printing to enhance their practices and provide personalized and affordable healthcare solutions to patients. Also, advancements such as multi-color and multi-material printing helps to imitate surgical environment for intra-operative reference and pre-surgical planning.

Asia Pacific Market, By Product

The syringe-based segment revenue was more than USD 126 million in 2021, owing to the extensive use of syringe-based printing technology in the medical field. The relatively higher penetration rate of the syringe-based products is the prime factor leading to its dominance in the market. Furthermore, the syringe-based 3D-printer can reduce the delay between design and prototype as well as simplify fabrication of microsystem. Also, affordable, and readily available 3D printing allow rapid prototyping of new ideas in the field of medicine.

Asia Pacific Healthcare 3D Printing Market, By Technology

The fused deposition modelling (FDM) segment will reach USD 485.4 million revenue by 2028, credited to ability for building functional parts that have complex geometrical shapes in a stipulated time span. Also, this technology offers printing of concept models, and end-use final products along with stability in dimensions. Further, key advantages of FDM prototypes include no changes in the size and shape of the printed material even when exposed to environment and it does not alter the part or features.

Asia Pacific Market, By Application

The dental application segment was valued at USD 95.6 million in 2021, attributed to high acceptability by patients and available customization at affordable price, allowing surgeons to replicate patients requirement based on CT and MRI scans. Further, increasing number of dental surgeons, flourishing medical tourism and favorable government policies are expected to increase the adoption of new technology including healthcare 3D printing.

Asia Pacific Market, By Country

China healthcare 3D printing market will witness 21% CAGR, to surpass USD 424.6 million revenue by 2028, owing to the presence of regional and small players of healthcare 3D printing. Also, increasing number of road accidents in the country is anticipated to further increase adoption rate of customized implants. Furthermore, growing technological adoption to advance outcomes of surgery and other medical activities will positively impact the market revenue.

Competitive Industry Landscape

Prominent participants operating across the Asia Pacific healthcare 3D printing market are Oventus Medical, Cyfuse Biomedical, 3D Systems, Renishaw, Stratasys Ltd and Carbon Inc. Companies use various strategies such as new product launch, collaborations, mergers, acquisitions, geographic expansions to strengthen their market position.